Vietnam’s second homegrown Covivac candidate vaccine will begin the second stage of clinical trials in the northern province of Thai Binh’s Vu Thu district on August 10.
Research centres on July 27 began the injection of the second shots of COVID-19 Nano Covax vaccine for 12,000 volunteers as part of the third-phase human trials of the home-grown vaccine, according to the Military Medical University under the Ministry of National Defence.
The first 240 volunteers in the third phase of the human trials of the home-grown Nano Covax COVID-19 vaccine received shots at the Vietnam Military Medical University in Hanoi on June 11.
More than 6,000 volunteers have registered for the third phase of human trials of homegrown Nano Covax vaccine, which is scheduled to begin on June 8, according to the Military Medical University (MMU) under the Defence Ministry.
The time for research and production of Nano Covax, Vietnam’s first candidate vaccine to reach human trial stage, has been shortened as much as possible, but safety has been ensured, said a health official.
Six out of 120 volunteers have been injected with Vietnam’s second homegrown candidate vaccine COVIVAC, as human trials began at the Hanoi Medical University on March 15.
The Hanoi-based Vietnam Military Medical University and the Pasteur Institute in Ho Chi Minh City have completed the administration of the first doses of Nano Covax in the second-stage human trials of this homegrown COVID-19 candidate vaccine.
A total of 367 volunteers, including 30 aged over 60, have been injected with Nano Covax, Vietnam’s first homegrown COVID-19 vaccine candidate, in the second phase of its human trials, according to the Military Medical University.
People, aged from 18-59 and residing in Hanoi, can register for human trials of Vietnam’s second COVID-19 vaccine candidate COVIVAC from March 5 morning.
The first 35 volunteers received injections of the locally-produced Nano Covax vaccine in the 2nd phase of human trials at the Military Medical University in Hanoi on February 26. Nanocovax is Vietnam’s first COVID-19 vaccine to reach the human trial stage.
The second phase of the human trials of Nano Covax, a homegrown COVID-19 vaccine, will begin on February 26, following the first phase that has been proven safe.
Vietnam has completed the first phase of the human trials of Nano Covax, a homegrown COVID-19 vaccine, with the participation of 60 volunteers, the Vietnam Military Medical University said on February 8.
A ceremony was held at the Hanoi Medical University on January 21 to kick-start clinical trials of COVIVAC, Vietnam’s second COVID-19 vaccine candidate and developed based on the new highly-infectious coronavirus variants.
Health
